Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(25.0%)
USD 0.01
(25.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 661 Thousand USD | 1422.0% |
| 2022 | -50 Thousand USD | -111.39% |
| 2021 | 439 Thousand USD | 693.24% |
| 2020 | -74 Thousand USD | 60.64% |
| 2019 | -188 Thousand USD | 33.33% |
| 2018 | -282 Thousand USD | -54.1% |
| 2017 | -183 Thousand USD | 25.91% |
| 2016 | -247 Thousand USD | 27.35% |
| 2015 | -340 Thousand USD | -81.82% |
| 2014 | -187 Thousand USD | 47.03% |
| 2013 | -353 Thousand USD | -508.62% |
| 2012 | -58 Thousand USD | 28.4% |
| 2011 | -81 Thousand USD | 55.25% |
| 2010 | -181 Thousand USD | -79.21% |
| 2009 | -101 Thousand USD | -773.33% |
| 2008 | 15 Thousand USD | 125.42% |
| 2007 | -59 Thousand USD | -296.67% |
| 2006 | 30 Thousand USD | 153.57% |
| 2005 | -56 Thousand USD | -119.51% |
| 2004 | 287 Thousand USD | 8.3% |
| 2003 | 265 Thousand USD | 6.85% |
| 2002 | 248 Thousand USD | -11.43% |
| 2001 | 280 Thousand USD | 1117.39% |
| 2000 | 23 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 767 Thousand USD | 16.04% |
| 2023 Q2 | 335 Thousand USD | 105.52% |
| 2023 Q3 | 438 Thousand USD | 30.75% |
| 2023 Q1 | 163 Thousand USD | 426.0% |
| 2023 FY | 661 Thousand USD | 1422.0% |
| 2023 Q4 | 661 Thousand USD | 50.91% |
| 2022 Q3 | -301 Thousand USD | -316.55% |
| 2022 Q4 | -50 Thousand USD | 83.39% |
| 2022 Q1 | 207 Thousand USD | -52.85% |
| 2022 Q2 | 139 Thousand USD | -32.85% |
| 2022 FY | -50 Thousand USD | -111.39% |
| 2021 FY | 439 Thousand USD | 693.24% |
| 2021 Q2 | -139 Thousand USD | -308.82% |
| 2021 Q3 | 15 Thousand USD | 110.79% |
| 2021 Q4 | 439 Thousand USD | 2826.67% |
| 2021 Q1 | -34 Thousand USD | 0.0% |
| 2020 FY | -74 Thousand USD | 60.64% |
| 2019 FY | -188 Thousand USD | 33.33% |
| 2018 FY | -282 Thousand USD | -54.1% |
| 2018 Q1 | -261 Thousand USD | 0.0% |
| 2018 Q2 | -209 Thousand USD | 19.92% |
| 2017 Q3 | -158 Thousand USD | 22.93% |
| 2017 Q1 | -211 Thousand USD | 14.57% |
| 2017 Q2 | -205 Thousand USD | 2.84% |
| 2017 FY | -183 Thousand USD | 25.91% |
| 2016 Q3 | -358 Thousand USD | -13.65% |
| 2016 Q1 | -251 Thousand USD | 26.18% |
| 2016 Q4 | -247 Thousand USD | 31.01% |
| 2016 FY | -247 Thousand USD | 27.35% |
| 2016 Q2 | -315 Thousand USD | -25.5% |
| 2015 Q2 | -329 Thousand USD | 1.2% |
| 2015 Q3 | -539 Thousand USD | -63.83% |
| 2015 Q4 | -340 Thousand USD | 36.92% |
| 2015 Q1 | -333 Thousand USD | -78.07% |
| 2015 FY | -340 Thousand USD | -81.82% |
| 2014 Q3 | -244 Thousand USD | 32.22% |
| 2014 Q2 | -360 Thousand USD | -18.03% |
| 2014 Q1 | -305 Thousand USD | 13.6% |
| 2014 Q4 | -187 Thousand USD | 23.36% |
| 2014 FY | -187 Thousand USD | 47.03% |
| 2013 Q4 | -353 Thousand USD | 2.49% |
| 2013 FY | -353 Thousand USD | -508.62% |
| 2013 Q2 | -134 Thousand USD | 29.1% |
| 2013 Q3 | -362 Thousand USD | -170.15% |
| 2013 Q1 | -189 Thousand USD | -225.86% |
| 2012 Q2 | 83 Thousand USD | 184.69% |
| 2012 Q3 | -62 Thousand USD | -174.7% |
| 2012 FY | -58 Thousand USD | 28.4% |
| 2012 Q4 | -58 Thousand USD | 6.45% |
| 2012 Q1 | -98 Thousand USD | -20.99% |
| 2011 Q3 | -75 Thousand USD | 14.77% |
| 2011 Q1 | -200 Thousand USD | -10.5% |
| 2011 Q4 | -81 Thousand USD | -8.0% |
| 2011 FY | -81 Thousand USD | 55.25% |
| 2011 Q2 | -88 Thousand USD | 56.0% |
| 2010 Q2 | -123 Thousand USD | -16.04% |
| 2010 Q3 | -183 Thousand USD | -48.78% |
| 2010 Q4 | -181 Thousand USD | 1.09% |
| 2010 FY | -181 Thousand USD | -79.21% |
| 2010 Q1 | -106 Thousand USD | -4.95% |
| 2009 Q2 | -5000.00 USD | 93.51% |
| 2009 FY | -101 Thousand USD | -773.33% |
| 2009 Q1 | -77 Thousand USD | -613.33% |
| 2009 Q4 | -101 Thousand USD | -48.53% |
| 2009 Q3 | -68 Thousand USD | -1260.0% |
| 2008 Q4 | 15 Thousand USD | -54.55% |
| 2008 FY | 15 Thousand USD | 125.42% |
| 2008 Q1 | -19 Thousand USD | 67.8% |
| 2008 Q2 | -16 Thousand USD | 15.79% |
| 2008 Q3 | 33 Thousand USD | 306.25% |
| 2007 Q3 | -52 Thousand USD | -173.68% |
| 2007 Q1 | -20 Thousand USD | -166.67% |
| 2007 FY | -59 Thousand USD | -296.67% |
| 2007 Q2 | -19 Thousand USD | 5.0% |
| 2007 Q4 | -59 Thousand USD | -13.46% |
| 2006 Q3 | 45 Thousand USD | 446.15% |
| 2006 FY | 30 Thousand USD | 153.57% |
| 2006 Q4 | 30 Thousand USD | -33.33% |
| 2006 Q1 | -60 Thousand USD | -7.14% |
| 2006 Q2 | -13 Thousand USD | 78.33% |
| 2005 Q1 | 168 Thousand USD | -41.46% |
| 2005 Q2 | 177 Thousand USD | 5.36% |
| 2005 FY | -56 Thousand USD | -119.51% |
| 2005 Q4 | -56 Thousand USD | -178.87% |
| 2005 Q3 | 71 Thousand USD | -59.89% |
| 2004 FY | 287 Thousand USD | 8.3% |
| 2004 Q4 | 287 Thousand USD | 7.49% |
| 2004 Q3 | 267 Thousand USD | 8.98% |
| 2004 Q2 | 245 Thousand USD | 52.17% |
| 2004 Q1 | 161 Thousand USD | -39.25% |
| 2003 Q4 | 265 Thousand USD | 15.22% |
| 2003 FY | 265 Thousand USD | 6.85% |
| 2003 Q1 | 268 Thousand USD | 8.06% |
| 2003 Q3 | 230 Thousand USD | -19.3% |
| 2003 Q2 | 285 Thousand USD | 6.34% |
| 2002 FY | 248 Thousand USD | -11.43% |
| 2002 Q1 | 294 Thousand USD | 5.0% |
| 2002 Q2 | 365 Thousand USD | 24.15% |
| 2002 Q4 | 248 Thousand USD | 22.77% |
| 2002 Q3 | 202 Thousand USD | -44.66% |
| 2001 Q3 | 331 Thousand USD | 13.36% |
| 2001 Q4 | 280 Thousand USD | -15.41% |
| 2001 FY | 280 Thousand USD | 1117.39% |
| 2001 Q2 | 292 Thousand USD | -17.51% |
| 2001 Q1 | 354 Thousand USD | 0.0% |
| 2000 FY | 23 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Achiko AG | 2.48 Million USD | 73.442% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.95 Million USD | 83.272% |
| Cannabis Sativa, Inc. | 206.45 Thousand USD | -220.162% |
| CompuMed, Inc. | -686.23 Thousand USD | 196.323% |
| CompuGroup Medical SE & Co. KGaA | 775.35 Million USD | 99.915% |
| Cogstate Limited | -29.45 Million USD | 102.244% |
| CareView Communications, Inc. | 19.88 Million USD | 96.675% |
| Craneware plc | 783 Thousand USD | 15.581% |
| Caduceus Software Systems Corp. | 2.38 Million USD | 72.321% |
| Certive Solutions Inc. | 5.68 Million USD | 88.369% |
| Drug Free Solution, Inc. | -12.5 Thousand USD | 5387.154% |
| DATATRAK International, Inc. | 103.82 Thousand USD | -536.642% |
| Strainsforpains, Inc. | 1.93 Million USD | 65.777% |
| Healixa Inc. | 6.5 Million USD | 89.837% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | -668.66 Thousand USD | 198.853% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 459.64 Thousand USD | -43.807% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5062.82 USD | -12955.965% |
| IQ-AI Limited | -176.63 Thousand USD | 474.229% |
| Cannabiz Mobile, Inc. | 494.04 Thousand USD | -33.794% |
| Mednow Inc. | 2.11 Million USD | 68.812% |
| Galileo Life Sciences, Inc. | 17.02 Thousand USD | -3782.754% |
| MediXall Group, Inc. | 2.81 Million USD | 76.54% |
| Mitesco, Inc. | 1.76 Million USD | 62.526% |
| MobileSmith, Inc. | 4.85 Million USD | 86.39% |
| NantHealth, Inc. | 265.64 Million USD | 99.751% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 8.48 Million USD | 92.209% |
| Patient Access Solutions, Inc. | 910.34 Thousand USD | 27.39% |
| Pharma-Bio Serv, Inc. | -10.09 Million USD | 106.545% |
| PPJ Healthcare Enterprises, Inc. | 2.54 Million USD | 74.017% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 22.939% |
| Renalytix Plc | 3.85 Million USD | 82.853% |
| Revium Recovery Inc. | -529 Thousand USD | 224.953% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -414.83 Thousand USD | 259.342% |
| Vaso Corporation | -9.28 Million USD | 107.121% |
| Vynleads, Inc. | 513.29 Thousand USD | -28.776% |